|
Forums33
Topics44,195
Posts519,911
Members14,168
| |
Most Online3,221
Oct 6th, 2025
|
|
Administrator/owner:
John (Dragonslayer)
Administrator:
Melinda (mig)
WebAdmin:
Timo (Timo)
Administrator:
Brad (wolverinefan)
Moderators:
· Tim (Dotyisle)
· Chelsea (Kiwi)
· Megan (Megan)
· Wendy (WendyR)
· John (Cheerful)
· Chris (fyrfytr187)
|
|
If you want to use this QR code (Quick Response code) just save the image and paste it where you want. You can even print it and use it that way. Coffee cups, T-Shirts etc would all be good for the QR code.
|
|
|
|
Joined: Oct 2001
Posts: 75
Apprentice_AS_Kicker
|
OP
Apprentice_AS_Kicker
Joined: Oct 2001
Posts: 75 |
I just saw a quick blurb on CNN in one of those moving subtitles that Merck was coming out with a successor to VIOXX. I didn't quite catch the name. Arvi-something-or-other. Does anyone here know anything about the drug?
TIA
Adam Rodman
|
|
|
|
|
Joined: Oct 2001
Posts: 75
Apprentice_AS_Kicker
|
|
OP
Apprentice_AS_Kicker
Joined: Oct 2001
Posts: 75 |
Watched CNN cycle again and caught the name this time.
Adam Rodman
|
|
|
|
|
Joined: Oct 2001
Posts: 1,022
Iron_AS_Kicker
|
|
Iron_AS_Kicker
Joined: Oct 2001
Posts: 1,022 |
Well what is it?.... You got me curious... Dan 
[align center] [/align]
|
|
|
|
|
Joined: Oct 2001
Posts: 75
Apprentice_AS_Kicker
|
|
OP
Apprentice_AS_Kicker
Joined: Oct 2001
Posts: 75 |
I don't know anything at all about it.
Anyone?
Adam Rodman
|
|
|
|
|
Joined: Dec 2001
Posts: 1,364
Bronze_AS_Kicker
|
|
Bronze_AS_Kicker
Joined: Dec 2001
Posts: 1,364 |
From Merck USA http://www.merck.com/newsroom/press_releases/research_and_development/2003_1230.htmlMerck Submits New Drug Application for ARCOXIA™ WHITEHOUSE STATION, N.J., Dec. 30, 2003 - Merck & Co., Inc. today announced it has submitted a New Drug Application for ARCOXIA™ (etoricoxib) to the U.S. Food and Drug Administration (FDA). The application was submitted today. Merck’s NDA seeks indications for ARCOXIA for the treatment of osteoarthritis, rheumatoid arthritis, chronic low back pain, acute pain, dysmenorrhea, acute gouty arthritis and ankylosing spondylitis. Within the next 60 days, the FDA will determine whether it will accept Merck’s application as submitted. ARCOXIA has been launched in 38 countries worldwide in Europe, Latin America and the Asia-Pacific region. From Merck Sharp & Dohme Limited in the UK where it is available. http://emc.medicines.org.uk/emc/assets/c/html/displaydoc.asp?documentid=8734Any of our friends over the pond use this? Doug
Doug  Kendra and Caleigh playing construction
|
|
|
|
|
Joined: Oct 2001
Posts: 75
Apprentice_AS_Kicker
|
|
OP
Apprentice_AS_Kicker
Joined: Oct 2001
Posts: 75 |
Interesting.
Thanks.
Adam Rodman
|
|
|
|
|
Joined: Feb 2004
Posts: 44
Member
|
|
Member
Joined: Feb 2004
Posts: 44 |
Ive lived with VIOXX for a year now, works excellent for me...
I recently tried ARCOXIA for a month and didnt like it, it doesnt work as strong like VIOXX, didnt work like vioxx, gave me nausea side effects for the first weeks...
Looks like my body reacts way much better with vioxx..
The price for arcoxia is not that bad.
A 25mg x 28 of Vioxx is about $65 here in Mexico
A 90mg x 28 of Arcoxia is about $70 here in Mexico
PS. Arcoxia has been in Mexico for a while but rearely used and prescribed, I really dont know why but in my experience its two thumbs up for vioxx...
|
|
|
|
|
Joined: Jan 2003
Posts: 40
Member
|
|
Member
Joined: Jan 2003
Posts: 40 |
Here's an article from Forbes on this new drug. Bad News: Merck Withdraws Arcoxia Application Matthew Herper, 03.15.02, 2:00 PM ET NEW YORK - Merck today withdrew its application with the Food and Drug Administration for Arcoxia, its next-generation painkiller. Many analysts had been expecting the drug to help Merck win a long-standing duel for the arthritis market with rival Pharmacia, which makes similar drugs. http://www.forbes.com/2002/03/15/0315mrk.htmlOne major issue, Butler says, is whether the drug would be approved to treat any form of chronic pain. Such an approval is essential for Arcoxia to beat Pharmacia's drugs. Merck's stated reason for withdrawing the application is that it wants a chronic-pain indication. The company says new data could result in Arcoxia being approved for a form of chronic back pain called ankylosing spondylitis. BEWARE, IT'S ALWAYS ABOUT THE MONEY! THERE'S A LINK ON THE ABOVE URL TO ANOTHER FORBES ARTICLE ABOUT NOVARTIS' NEW ARTHRITIS DRUG...COX-189 Rowr  "Rumors of my death are greatly exaggerated."Mark Twain
"Rumors of my death are greatly exaggerated."Mark Twain
|
|
|
|
|
Joined: Mar 2004
Posts: 3
New_Member
|
|
New_Member
Joined: Mar 2004
Posts: 3 |
Hello Kmu,
I'm experiencing the opposit, Vioxx has little effect and Arcoxia is the most effective,
Still trying to find the best compromise between effectiveness and long term side effects,
Best, S.
|
|
|
|
|
Joined: Apr 2004
Posts: 1
Lurker
|
|
Lurker
Joined: Apr 2004
Posts: 1 |
I Participated in a clinical trial in 2001 for Merck. I beleive this is the drug I was on. It was great. I hadn't felt that good in over 20 years. All through the trial I kept asking my doc what was going to happen at the end of the year long study. He said that I was on the second trial because Merck wanted a "little more data" for their submission. They would probably continue to supply me with free medicine until is became available to buy.
At the end of the year, I was told that Merck would not continue the medicine. I was taken off cold turkey. My doc was upset because he had never seen this happen in previous trials and Merck would not tell him why.
They did agree to give me Vioxx for free which I questioned because at that time, Vioxx was not "approved" for AS.
6 months later, September 10,2001 I suffered a heart attack. No previous history. Cardiology could not say why it happened. All he did say was that I should never take a cox-2 again. My Rhrumy agreed and I've been on it since.
I'm not trying to scare or taint any help, but there are always two sides to a story.
|
|
|
|
1 members (1 invisible),
865
guests, and
332
robots. |
|
Key:
Admin,
Global Mod,
Mod
|
|
|
|
